JAK3 is particularly significant due to its association with cytokine-driven immune cell activation, suggesting that APS may enhance the proliferation and activity of immune cells targeting AML cells (Yamaoka and Kitamura, 2023; Li G. et al., 2023). Here, JAK3 is linked to acute myeloid leukemia.